Is NVACR or DIVO a better dividend investment in 2026?

NVACR currently yields 869.19% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: NVACR offers higher current income.

What is the dividend yield difference between NVACR and DIVO?

NVACR has a forward dividend yield of 869.19% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 862.70 percentage points.

Home › Compare › NVACR vs DIVO

NVACR vs DIVO: Dividend Comparison 2026

NVACR yields 869.19% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NVACR wins by $5614694.34M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NVACR

● Live price

869.19%

Share price

$0.23

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5614694.37M

Annual income

$4,578,487,568,019.30

Full NVACR calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — NVACR vs DIVO

📍 NVACR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NVACR	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NVACR + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NVACR pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVACR

Annual income on $10K today (after 15% tax)

$73,880.92/yr

After 10yr DRIP, annual income (after tax)

$3,891,714,432,816.41/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, NVACR beats the other by $3,891,714,431,981.98/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVACR + DIVO for your $10,000?

NVACR: 50%DIVO: 50%

100% DIVO50/50100% NVACR

Portfolio after 10yr

$2807347.20M

Annual income

$2,289,243,784,500.49/yr

Blended yield

81.54%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVACR buys

DIVO buys

No recent congressional trades found for NVACR or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNVACRDIVO

Forward yield	869.19% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$5614694.37M ✓	$30.7K
Annual income after 10y	$4,578,487,568,019.30 ✓	$981.68
Total dividends collected	$5533850.18M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: NVACR vs DIVO ($10,000, DRIP)

Year	NVACR Portfolio	NVACR Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$97,619	$86,918.73	$11,349	$649.42	+$86.3K → NVACR
2	$897,433	$792,980.95	$12,833	$688.83	+$884.6K → NVACR
3	$7,773,402	$6,813,148.51	$14,459	$727.90	+$7.76M → NVACR
4	$63,471,051	$55,153,510.62	$16,238	$766.49	+$63.45M → NVACR
5	$488,789,822	$420,875,798.13	$18,179	$804.47	+$488.77M → NVACR
6	$3,552,126,256	$3,029,121,146.65	$20,293	$841.71	+$3552.11M → NVACR
7	$24,373,845,142	$20,573,070,047.70	$22,591	$878.14	+$24373.82M → NVACR
8	$158,012,267,852	$131,932,253,550.37	$25,087	$913.65	+$158012.24M → NVACR
9	$968,417,572,696	$799,344,446,093.61	$27,791	$948.18	+$968417.54M → NVACR
10	$5,614,694,370,804	$4,578,487,568,019.30	$30,718	$981.68	+$5614694.34M → NVACR

NVACR vs DIVO: Complete Analysis 2026

NVACR — Stock

NorthView Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus its search on target businesses in the healthcare sector. The company was incorporated 2021 and is based in New York, New York. NorthView Acquisition Corporation operates as a subsidiary of NorthView Sponsor I, LLC.

Full NVACR Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this NVACR vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVACR vs SCHD NVACR vs JEPI NVACR vs O NVACR vs KO NVACR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.